Skip to the content

KD&A - Regulatory Consultants for Medical and IVD devices

kdent@kdas.com.au
logo mainlogo darklogo light
  • About Us
    • About Us
    • What our Clients Say
    • Frequently Asked Questions
  • Our Services
    • Medical Device Regulatory Strategy
    • ISO 13485/ MDSAP QMS Maintenance, Internal Audit and Support
    • Technical File Documentation
    • Global Medical Device Registrations including ARTG Inclusions/TGA Registrations
    • Post Market Surveillance
    • TGA Conformity Assessment / CE Marking
    • Promotional Materials Review
    • Australian TGA Sponsor Services
    • Medical Device and IVD Classification Assessment
    • Software as a Medical Device (SaMD)
  • Our Clients
    • Australian Sponsors & Distributors
    • Medical Device Manufacturers
    • International Medical Device Manufacturers
    • Our Clients
  • News
  • Useful Links
Get In Touch
logo main
  • About Us
    • What our Clients Say
    • Frequently Asked Questions
    • Useful Links
  • Our Services
    • Medical Device Regulatory Strategy
    • ISO 13485/ MDSAP QMS Maintenance, Internal Audit and Support
    • Technical File Documentation
    • Global Medical Device Registrations including ARTG Inclusions/TGA Registrations
    • Post Market Surveillance
    • TGA Conformity Assessment / CE Marking
    • Promotional Materials Review
    • Australian TGA Sponsor Services
    • Medical Device and IVD Classification Assessment
    • Software as a Medical Device (SaMD)
  • Our Clients
    • Australian Sponsors & Distributors
    • Medical Device Manufacturers
    • International Medical Device Manufacturers
  • Latest News
  • Contact Us

Medicinal Substances Tag

06
Dec
Regulatory ChangesResearchTGA

KD&A Can Help You From the Start – Medical Devices Steps to Market

Do you have a medical device and don’t know what to do? Medical devices include a wide range of products from bandages to heart valves and in most regions, the term medical devic

Read More
Share
01
Sep
Regulatory ChangesResearchTGA

New Regulatory Changes for Medical Devices Containing Medicinal Substances, Animal, Microbial, or Recombinant Materials

As of 1 July 2024, new regulatory requirements for medical devices containing medicinal substances, or materials derived from animal, microbial, or recombinant sources will take ef

Read More
Share
16
Sep
Regulatory ChangesResearchTGA

Important Changes in the Regulatory Framework for IVDs

Goods new for laboratories that manufacture Class 4 in-house IVDs. A new conformity assessment procedure has been introduced.

Read More
Share
09
Dec
Regulatory ChangesResearchTGA

Therapeutic Goods Administration (TGA) Introduce Online Medical Device Incident Reporting (MDIR) System

The TGA have introduced a new online MDIR System for sponsors and manufacturers which is accessible via their eBusiness system (also used to submit applications). The eBusiness sys

Read More
Share
21
Nov
Regulatory ChangesResearchTGA

Medical Device Single Audit Program (MDSAP)

The International Medical Device Regulators Forum (IMDRF) began work on developing documentation to facilitate the Medical Device Single Audit Program (MDSAP) in Singapore in 2012.

Read More
Share
29
Aug
Regulatory ChangesResearchTGA

TGA Medical Device Reforms – Product Names Requirement Cancelled

The TGA have announced that a component of the medical device reforms outlined in the TGA blueprint will not go ahead. The initiative to record all devices included under a device

Read More
Share
29
Aug
Regulatory ChangesResearchTGA

NZ Medical Device Recalls Remind Medical Device Suppliers to be Prepared

New Zealand (NZ)’s regulatory body for therapeutic goods, Medsafe, have issued a reminder to medical device suppliers to ensure they are suitability prepared for a recall should

Read More
Share
18
Jul
Regulatory ChangesResearchTGA

Hip, Knee and Shoulder Joint Reclassification: Only 12 Months Remain

The TGA are working towards the deadline of 30 July 2014 to finalise the reclassification of total or partial hip, knee and should joints. In another step towards this deadline, th

Read More
Share
03
Jul
Regulatory ChangesResearchTGA

Information Feature: TGA Application Audit

As of 1 July 2024, new regulatory requirements for medical devices containing medicinal substances, or materials derived from animal, microbial, or recombinant sources will take ef

Read More
Share
17
Jun
Regulatory ChangesResearchTGA

Workshop – Key Topic Information

As of 1 July 2024, new regulatory requirements for medical devices containing medicinal substances, or materials derived from animal, microbial, or recombinant sources will take ef

Read More
Share

Posts pagination

01 02
News Categories
  • EU
  • FDA
  • Regulatory Changes
  • Research
  • Software
  • Technology
  • TGA
  • Uncategorized
Latest Articles
March 20, 2025
Understanding Requirements for Medical Devices Containing Medicinal, Microbial, Recombinant, or Animal Origin Substances
February 13, 2025
TGA Recall Reforms: A Closer Look at the PRAC
December 6, 2024
KD&A Can Help You From the Start – Medical Devices Steps to Market
Tags

Australia Australian Medical Device Regulatory Framework European Union Manufacturer's Evidence Medical Device Medical Device Regulations Medicinal Substances Regulatory Changes Regulatory Compliance Regulatory Requirements Regulatory Strategy TGA

  • What We Do
  • Who We Help
  • What our Clients Say
+ 61 411 101 392
kdent@kdas.com.au

Get our latest expert updates to your inbox

KD&A provides expert regulatory consulting service to medical device and IVD companies selling on Australian and International markets.

    Contact us:
    kdent@kdas.com.au
    +61 411 101 392
    Our address:
    Level 3, Suite 301,
    27 Belgrave Street,
    Manly NSW, Australia
    Our social:
    Terms and conditions
    Privacy policy
    © 2025 KD&A Pty Ltd
    w

    Lorem ipsum dolor sit amet, consectetur adipiscing elit eiusmod tempor

    w
    leroux@qodeinteractive.com